Myeloma UK

Homepage: myeloma.org.uk

ROR: 01wes1575

OpenAlex ID: I4210120249

Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma

2004 · Richard Soutar, Helen Lucraft, et al. · British Journal of Haematology · 450

PDF

Guidelines for the diagnosis and management of multiple myeloma 2011

2011 · Jennifer M. Bird, Roger G. Owen, et al. · British Journal of Haematology · 306

Guidelines for supportive care in multiple myeloma 2011

2011 · John A. Snowden, Sam H. Ahmedzai, et al. · British Journal of Haematology · 206

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

2019 · Mark T Drayson, Stella Bowcock, et al. · The Lancet Oncology · 168

PDF

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)

2009 · Jenny Bird, Judith Behrens, et al. · British Journal of Haematology · 134

Guidelines for the use of imaging in the management of patients with myeloma

2017 · Andrew Chantry, Majid Kazmi, et al. · British Journal of Haematology · 131

PDF

Guidelines for the use of imaging in the management of myeloma

2007 · Shirley D'Sa, Niels Abildgaard, et al. · British Journal of Haematology · 111

PDF

In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor®), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae

1997 · P.C.T Hannan, H.M Windsor, et al. · Research in Veterinary Science · 96

Guidelines for screening and management of late and long‐term consequences of myeloma and its treatment

2017 · John A. Snowden, Diana M. Greenfield, et al. · British Journal of Haematology · 67

PDF

Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma

2017 · Douwe Postmus, Sarah Richard, et al. · The Oncologist · 64

Why Patients Should Be Involved in Health Technology Assessment

2017 · Janet Wale, Anna Mae Scott, et al. · International Journal of Technology Assessment in Health Care · 56

PDF

Comparative Susceptibilities of Various Aids-Associated and Human Urogenital Tract Mycoplasmas and Strains of Mycoplasma Pneumoniae to 10 Classes of Antimicrobial Agent In Vitro

1998 · P. C. T. Hannan · Journal of Medical Microbiology · 55

Living with the burden of relapse in multiple myeloma from the patient and physician perspective

2017 · Cyrille Hulin, Timon Hansen, et al. · Leukemia Research · 43

PDF

Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial

2016 · Rakesh Popat, Sarah R Brown, et al. · The Lancet Haematology · 43

Immunization With a Recombinant MAGE-A3 Protein After High-dose Therapy for Myeloma

2007 · Susann Szmania, Sacha Gnjatic, et al. · Journal of Immunotherapy · 41

Environmental DNA reveals links between abundance and composition of airborne grass pollen and respiratory health

2021 · Francis M. Rowney, Georgina L. Brennan, et al. · Current Biology · 40

PDF

Future of CAR T cells in multiple myeloma

2020 · Kitsada Wudhikarn, Sham Mailankody, et al. · Hematology · 33

Optimizing the management of patients with spinal myeloma disease

2015 · Sean Molloy, Maggie Lai, et al. · British Journal of Haematology · 32

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma

2024 · Bachisio Ziccheddu, Claudia Giannotta, et al. · Blood Cancer Journal · 29

Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK

2020 · Simon Fifer, Jayne Galinsky, et al. · Patient Preference and Adherence · 26

PDF

Updates to the guidelines for the diagnosis and management of multiple myeloma

2014 · Guy Pratt, Matthew Jenner, et al. · British Journal of Haematology · 24

PDF

Current Approach to Diagnosis and Management of Acute Renal Failure in Myeloma Patients

2012 · Nelson Leung, Judith Behrens · Advances in Chronic Kidney Disease · 24

PDF

Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four Trial

2020 · Sarah Brown, Charlotte Pawlyn, et al. · Clinical Lymphoma Myeloma & Leukemia · 22

Immune response to COVID ‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response

2022 · Karthik Ramasamy, Ross Sadler, et al. · British Journal of Haematology · 21

PDF

Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy

2019 · Graham Jackson, Jayne Galinsky, et al. · European Journal Of Haematology · 21

PDF

Works count: 92

Citation count: 3,342